New Drug Approvals

JULY 18, 2025

China Patent CN 115960147, 2023. (10) Zhu KW (2023). “Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials” Frontiers in Pharmacology. Retrieved 2023-01-03. Retrieved 2023-01-03. Further reading Zhu KW (2023). Target Ther.

RNA 62

RNA Clinical Trials Trials Virus 62

Drug Target Review

MARCH 12, 2024

2023 February 5 [2024 March 11]; 15(1). Biochemical Pharmacology. 2023 December 9 [2024 March 11] Available from: [link] 3 Abiead Y, Aiosa N, Antunes E, et al. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. Available from: [link] 2 Biagoli M, Distrutti E, Fiorucci S, et al.

Disease 111

Disease Biochemical Pharmacology FDA Approval Pharmacy 111

Drug Target Review

JUNE 6, 2023

He is also a member of the Translator Scientific Advisory Committee at Harvard Medical School, an Associate Editor at Journal of Pharmacology and Experimental Therapeutics, a member of the Editorial Board at Biochemical Pharmacology and Fellow of the American Heart Association (Council for High Blood Pressure Research).

Engineering 98

Engineering Immune Response Biochemical Pharmacology Clinical Trials 98

New Drug Approvals

APRIL 19, 2025

“Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors” Biochemical Pharmacology. Retrieved 25 February 2025. ^ “Delving into the Latest Updates on Bivamelagon with Synapse” Synapse. 23 January 2025. Retrieved 25 February 2025. Aronne, Sarah R. Barenbaum, Louis J. August 2022).

Biochemical Pharmacology 62

Biochemical Pharmacology Small Molecule Clinical Trials International 62